Table 1.
Treatment regimens and eradication rates among various groups of mice infected by H. pylori.
| Group | Name | n | Treatment regimen1 | H. pylori (+)/(−) | Eradication2 | |
|---|---|---|---|---|---|---|
| Exp1 | Exp2 | rate (%) | ||||
| A | UC (uninfected control) | 10 | — | 0/5 | 0/5 | NA |
| B | IC (infected control) | 20 | — | 10/0 | 10/0 | 0 |
| C | TT (treatment control 1) | 20 | Triple therapy for 7 days | 1/9 | 1/9 | 90* |
| D | CA7 (treatment control 2) | 20 | CA solution for 7 days | 10/0 | 9/1 | 5 |
| E | SA7 (treatment control 3) | 20 | SA solution for 7 days | 9/1 | 10/0 | 5 |
| F | CASA7 | 40 | CASA solution for 7 days | 6/14 | 4/16 | 75* |
| G | CASA10 | 40 | CASA solution for 10 days | 1/19 | 1/19 | 95∗# |
| H | CASA14 | 40 | CASA solution for 14 days | 1/19 | 1/19 | 95∗# |
1CA solution, 1% glucose and 640 mg/L CA; SA solution, 1% glucose and 160 mg/L SA; CASA solution, 1% glucose and a mixture of 640 mg/L CA and 160 mg/L SA.
2NA: not available. *P < 0.001, compared to the CA7 or SA7 group; # P = 0.01, compared to the CASA7 group.